经皮股动脉穿刺术后两种穿刺点压迫止血方法的效果对比  

Comparison of the hemostasis of compression devices and manual compression after femoral artery puncture

作　　者：童为燕 吴文俊 秦杰 TONG Wei- yan;WU Wen- jun;QIN Jie(Nursing Department,General Hopital,Central Theate,PLA,Wuhan 430070,China)

机构地区：[1]中国人民解放军中部战区总医院护理部,武汉430070 [2]中国人民解放军中部战区总医院神经外科,武汉430070

出　　处：《中国临床神经外科杂志》2019年第7期419-421,共3页Chinese Journal of Clinical Neurosurgery

摘　　要：目的对比经皮股动脉穿刺术后压迫器止血法和传统手指压迫止血法压迫股动脉穿刺点的安全性、有效性。方法回顾性分析2016年7月至2019年1月经皮穿刺股动脉术干预的2 031例病人的临床资料。结果 2 031例共2 068个穿刺点,其中1 055个穿刺点采用压迫器压迫止血(压迫器组),1 013个穿刺点采用传统手指压迫止血(指压组)。压迫器组1055个穿刺点中,5个(0.5%)穿刺点术后出现假性动脉瘤,2个(0.2%)穿刺点出现动静脉瘘,11个(1.0%)穿刺点出现渗血、血肿形成。指压组1013个穿刺点中,12个(1.2%)穿刺点术后出现假性动脉瘤,6个(0.6%)穿刺点出现动静脉瘘,38个(3.8%)穿刺点出现渗血、血肿形成。压迫器组术后并发症总发生率(1.7%)明显低于指压组(5.4%;P<0.05)。结论经皮股动脉穿刺术后采用压迫器压迫穿刺点止血优于传统手指压迫穿刺点止血。Objective To compare the safety and effectiveness of the compression devices and manual compression on the hemostasis after the femoral artery puncture for cerebral angiography or endovascular treatment of cerebrovascular disease. Methods The clinical data of 2 031 patients who underwent the femoral artery puncture for cerebral angiography or endovascular treatment of cerebrovascular disease from July 2016 to January 2019 we retrospectively analyzed. Results These 2 031 patients had 2 068 puncture points, of which 1 055 puncture points were compressed by the compression devices (device group) and 1 013 puncture points were pressed by the manual compression (manual group). There were 5 (0.5%) pseudoaneurysms, 2 (0.2%) arteriovenous fistulas, and 11 (1.0%) hematomas in device group after the puncture. There were 12 (1.2%) pseudoaneurysms, 6 (0.6%) arteriovenous fistulas, and 38 (3.8%) hematomas in manual group after the puncture. The total incidence of complications in the device group (1.7%) was significantly lower than that (5.4%) of the manual group (P<0.05). Conclusion The hemostasis efficacy of the compression devices is better than that of the manual compression after the femoral artery puncture.

关 键 词：股动脉穿刺术 传统手指压迫止血 压迫器压迫止血 安全性 有效性 

分 类 号：R743[医药卫生—神经病学与精神病学] R815.2[医药卫生—临床医学]